Thomas J. Shaw Purchases 22,620 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 22,620 shares of the stock in a transaction on Monday, May 5th. The stock was bought at an average cost of $0.71 per share, for a total transaction of $16,060.20. Following the transaction, the chief executive officer now owns 15,248,354 shares of the company’s stock, valued at approximately $10,826,331.34. This trade represents a 0.15 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.

Retractable Technologies Trading Down 1.1 %

Shares of Retractable Technologies stock opened at $0.75 on Wednesday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The stock has a market capitalization of $22.46 million, a P/E ratio of -1.39 and a beta of 1.65. Retractable Technologies, Inc. has a 52-week low of $0.56 and a 52-week high of $1.22. The stock’s 50-day simple moving average is $0.73 and its 200 day simple moving average is $0.72.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Retractable Technologies stock. Wealthfront Advisers LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned approximately 8.46% of Retractable Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 7.58% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on Retractable Technologies in a report on Tuesday. They set a “hold” rating for the company.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.